About Test
Introducing Testology's Female Cancer Panel Extended—a comprehensive diagnostic solution meticulously tailored to assess key biomarkers associated with female-specific cancers. Our panel includes an extensive array of tests, covering essential markers such as CA 15-3, CA 19-9, CA 125, AFP (Alpha-Fetoprotein), B-HCG (Beta-Human Chorionic Gonadotropin), and CEA (Carcinoembryonic Antigen), providing valuable insights into breast, ovarian, liver, and other cancer risks in women.
CA 15-3, CA 19-9, and CA 125 serve as tumor markers for breast and ovarian cancers respectively, while AFP is crucial for monitoring liver cancer. Additionally, B-HCG testing is vital for detecting pregnancy-related cancers, and CEA testing aids in the assessment of colorectal and other cancers, enabling proactive management and timely intervention.
With precise testing for these biomarkers, our Female Cancer Panel Extended empowers early detection and proactive management of cancer risks specific to women.
At Testology, we prioritize accuracy, confidentiality, and convenience, ensuring that your test results are delivered with precision and discretion.
Trust Testology to be your partner in promoting proactive health management and early detection of female-specific cancers. Take control of your health with Testology's Female Cancer Panel Extended, and gain peace of mind knowing that you're prioritizing your well-being.
​
Female Cancer Panel Extended includes the following:
​
-
CA 15-3
-
CA 19-9
-
CA 125
-
AFP, Tumor Marker
-
B-HCG, Qualitative, Serum
-
CEA
To view panel description click here